Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ: OPK) of the November 13, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company
| NEW YORK, /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in OPKO Health, Inc. (“OPKO” or the “Company”) (NASDAQ: OPK) of the November 13, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in OPKO Health, Inc. stock or options between September 26, 2013 and September 7, 2018 and would like to discuss your legal rights, click here: www.faruqilaw.com/OPK. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. CONTACT: The lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all those who purchased OPKO securities between September 26, 2013 and September 26, 2018 (the “Class Period”). The case, Kerznowski v. OPKO Health, Inc., No. 18-cv-13834 was filed on September 12, 2018. The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) Defendant Frost and OPKO were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; and (2) this illicit scheme would result in governmental scrutiny including from the SEC. Specifically, on September 7, 2018, the SEC issued a press release entitled ‘SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes.’ On this news, the Company’s share price fell from $5.58 per share on September 6, 2018 to $4.58 per share on September 7, 2018--a $1.01 or 18.07% drop. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding OPKO’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. View original content to download multimedia:http://www.prnewswire.com/news-releases/lead-plaintiff-deadline-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-exceeding-100-000-in-opko-health-inc-to-contact-the-firm-300713933.html SOURCE Faruqi & Faruqi, LLP | ||
Company Codes: NASDAQ-NMS:OPK |
